{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:24:57Z","timestamp":1793521497576,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jcmg.2025.03.017","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T18:34:21Z","timestamp":1754332461000},"page":"912-927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Accelerating Drug Translation"],"prefix":"10.1016","volume":"18","author":[{"given":"Lohendran","family":"Baskaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utkarsh","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1733-4109","authenticated-orcid":false,"given":"Wang","family":"Xiaomeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-3011","authenticated-orcid":false,"given":"Michael Patrick","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2362-6498","authenticated-orcid":false,"given":"Kelley","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Blankstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9876-4049","authenticated-orcid":false,"given":"Pamela S.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5080-6083","authenticated-orcid":false,"given":"Gemma A.","family":"Figtree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2025.03.017_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.15445","article-title":"Costs of drug development and research and development intensity in the US, 2000-2018","volume":"7","author":"Sertkaya","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcmg.2025.03.017_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIR.0000000000000981","article-title":"A call to action for new global approaches to cardiovascular disease drug solutions","volume":"144","author":"Figtree","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2025.03.017_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jacbts.2016.03.012","article-title":"Temporal trends and factors associated with cardiovascular drug development, 1990 to 2012","volume":"1","author":"Hwang","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jcmg.2025.03.017_bib4","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jacc.2019.08.012","article-title":"From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review","volume":"74","author":"Ahmadi","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib5","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2018.02.079","article-title":"Coronary atherosclerotic precursors of acute coronary syndromes","volume":"71","author":"Chang","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrcardio.2014.60","article-title":"Comprehensive plaque assessment by coronary CT angiography","volume":"11","author":"Maurovich-Horvat","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/jcm10030521","article-title":"Potential application of cardiac computed tomography for early detection of coronary atherosclerosis: from calcium score to advanced atherosclerosis analysis","volume":"10","author":"Conte","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcmg.2025.03.017_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcin.2010.10.008","volume":"4","author":"Voros","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcmg.2025.03.017_bib9","series-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","year":"2016"},{"key":"10.1016\/j.jcmg.2025.03.017_bib10","series-title":"Clinical Measurement in Drug Evaluation","first-page":"3","article-title":"Clinical measurement in drug evaluation: a regulatory authority\u2019s opinion about surrogate endpoints","author":"Temple","year":"1995"},{"key":"10.1016\/j.jcmg.2025.03.017_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jacc.2007.03.044","article-title":"Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes","volume":"50","author":"Motoyama","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib12","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.jcmg.2022.07.002","volume":"15","author":"Cury","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib13","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/0735-1097(96)00071-X","article-title":"Contribution of inadequate compensatory enlargement to development of human coronary artery stenosis: an in vivo intravascular ultrasound study","volume":"27","author":"Nishioka","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0735-1097(98)00304-0","article-title":"Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox","volume":"32","author":"Pasterkamp","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jcmg.2012.09.016","article-title":"Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome","volume":"6","author":"Otsuka","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcct.2020.03.005","article-title":"Association of high-risk coronary atherosclerosis at CCTA with clinical and circulating biomarkers: insight from CAPIRE study","volume":"15","author":"Conte","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jcct.2024.06.009","article-title":"Biomarkers for identification of high-risk coronary plaques in patients with suspected coronary artery disease","volume":"18","author":"Pedersen","year":"2024","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jcmg.2022.03.016","article-title":"Coronary atherosclerosis, cardiac troponin, and interleukin-6 in patients with chest pain: the PROMISE trial results","volume":"15","author":"Ferencik","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcct.2023.10.011","article-title":"Low-attenuation coronary plaque burden and troponin release in chronic coronary syndrome: a mediation analysis","volume":"18","author":"Vecsey-Nagy","year":"2024","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","article-title":"Effects of statins on coronary atherosclerotic plaques: the PARADIGM study","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib21","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.3390\/jcm9103338","article-title":"Effect of evolocumab on vulnerable coronary plaques: a serial coronary computed tomography angiography study","volume":"9","author":"Hirai","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcmg.2025.03.017_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006973","article-title":"Computed tomographic coronary angiography-derived plaque characteristics predict major adverse cardiovascular events: a systematic review and meta-analysis","volume":"11","author":"Nerlekar","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib23","first-page":"1170","article-title":"Evaluation of coronary plaque characteristics with coronary computed tomography angiography in patients with non-obstructive coronary artery disease: a long-term follow-up study","volume":"18","author":"Conte","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jcct.2013.05.008","article-title":"Noncalcified atherosclerotic lesions with vulnerable characteristics detected by coronary CT angiography and future coronary events","volume":"7","author":"Yamamoto","year":"2013","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamacardio.2017.4973","article-title":"Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial","volume":"3","author":"Ferencik","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2018.10.066","article-title":"Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study","volume":"73","author":"Williams","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jcct.2024.05.232","article-title":"Standards for quantitative assessments by coronary computed tomography angiography (CCTA): an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT)","volume":"18","author":"Nieman","year":"2024","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcct.2020.11.002","article-title":"Society of Cardiovascular Computed Tomography\/North American Society of Cardiovascular Imaging\u2014expert consensus document on coronary ct imaging of atherosclerotic plaque","volume":"15","author":"Shaw","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcct.2020.01.012","article-title":"Percent atheroma volume: optimal variable to report whole-heart atherosclerotic plaque burden with coronary CTA, the PARADIGM study","volume":"14","author":"van Rosendael","year":"2020","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib30","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART)","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2025.03.017_bib31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jcmg.2023.02.002","article-title":"Advances in coronary computed tomographic angiographic imaging of atherosclerosis for risk stratification and preventive care","volume":"16","author":"Bienstock","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib32","article-title":"Diagnostic performance of AI-enabled plaque quantification from coronary CT angiography compared with intravascular ultrasound","volume":"6","author":"Ihdayhid","year":"2024","journal-title":"Radiol Cardiothorac Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib33","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1016\/S2589-7500(22)00022-X","article-title":"Deep learning-enabled coronary CT angiography for plaque and stenosis quantification and cardiac risk prediction: an international multicentre study","volume":"4","author":"Lin","year":"2022","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.jcmg.2025.03.017_bib34","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/ehjci\/jeae115","article-title":"Prospective deep learning-based quantitative assessment of coronary plaque by computed tomography angiography compared with intravascular ultrasound: the REVEALPLAQUE study","volume":"25","author":"Narula","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib35","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3348\/kjr.2023.1311","article-title":"Application of quantitative assessment of coronary atherosclerosis by coronary computed tomographic angiography","volume":"25","author":"Lee","year":"2024","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcct.2021.07.001","article-title":"Quantitative assessment of atherosclerotic plaque, recent progress and current limitations","volume":"16","author":"Williams","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcct.2015.11.003","article-title":"Reproducibility of semi-automatic coronary plaque quantification in coronary CT angiography with sub-mSv radiation dose","volume":"10","author":"Ovrehus","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcct.2020.12.008","article-title":"Reproducibility of quantitative plaque measurement in advanced coronary artery disease","volume":"15","author":"Meah","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib39","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.122.060308","article-title":"Noninvasive plaque imaging to accelerate coronary artery disease drug development","volume":"146","author":"Figtree","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2025.03.017_bib40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1148\/radiol.2016161670","article-title":"Coronary CT angiography: variability of CT scanners and readers in measurement of plaque volume","volume":"281","author":"Symons","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jcmg.2025.03.017_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2022.04.011","article-title":"Differences of inflammatory cytokine profile in patients with vulnerable plaque: a coronary CTA study","volume":"350","author":"Roesner","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcmg.2025.03.017_bib42","doi-asserted-by":"crossref","first-page":"e2114923","DOI":"10.1001\/jamanetworkopen.2021.14923","article-title":"Assessment of coronary artery disease with computed tomography angiography and inflammatory and immune activation biomarkers among adults with HIV eligible for primary cardiovascular prevention","volume":"4","author":"Hoffmann","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcmg.2025.03.017_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcct.2015.10.001","article-title":"Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide","volume":"10","author":"Altintas","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib44","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/heartjnl-2022-321867","article-title":"Coronary low-attenuation plaque and high-sensitivity cardiac troponin","volume":"109","author":"Meah","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.jcmg.2025.03.017_bib45","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/ehjci\/jey012","article-title":"Impact of statin therapy on coronary plaque burden and composition assessed by coronary computed tomographic angiography: a systematic review and meta-analysis","volume":"19","author":"Andelius","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009750","article-title":"Impact of clinical characteristics and statins on coronary plaque progression by serial computed tomography angiography","volume":"13","author":"Smit","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib47","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamacardio.2021.3055","article-title":"Association of statin treatment with progression of coronary atherosclerotic plaque composition","volume":"6","author":"van Rosendael","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.atherosclerosis.2015.06.007","article-title":"Effects of intensive lipid-lowering therapy on coronary plaques composition in patients with acute myocardial infarction: assessment with serial coronary CT angiography","volume":"241","author":"Auscher","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcmg.2025.03.017_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jcmg.2016.04.013","article-title":"Impact of intensive LDL cholesterol lowering on coronary artery atherosclerosis progression: a serial CT angiography study","volume":"10","author":"Shin","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCIMAGING.110.937169","article-title":"Treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) in patients with recent acute coronary syndrome","volume":"3","author":"Tardif","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/thx.44.4.313","article-title":"Haemophilus influenzae type b infections in adults","volume":"44","author":"Round","year":"1989","journal-title":"Thorax"},{"key":"10.1016\/j.jcmg.2025.03.017_bib52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmg.2025.03.017_bib54","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehaa652","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial","volume":"41","author":"Budoff","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2025.03.017_bib55","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmg.2025.03.017_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2019.02.011","article-title":"Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): effects of pitavastatin on coronary artery disease and inflammatory biomarkers","volume":"212","author":"Hoffmann","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcmg.2025.03.017_bib57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jcmg.2010.04.011","article-title":"Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention","volume":"3","author":"Inoue","year":"2010","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.jcmg.2025.03.017_bib58","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1253\/circj.CJ-11-0139","article-title":"Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. Evaluation using dual-source computed tomography","volume":"75","author":"Soeda","year":"2011","journal-title":"Circ J."},{"key":"10.1016\/j.jcmg.2025.03.017_bib59","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.atherosclerosis.2013.08.019","article-title":"Effect of statin treatment on coronary plaque progression\u2014a serial coronary CT angiography study","volume":"231","author":"Zeb","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcmg.2025.03.017_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ahj.2016.06.023","article-title":"Effects of statin therapy on progression of mild noncalcified coronary plaque assessed by serial coronary computed tomography angiography: a multicenter prospective study","volume":"180","author":"Li","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcmg.2025.03.017_bib61","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/clc.22646","article-title":"Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study","volume":"40","author":"Matsumoto","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib62","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA."},{"key":"10.1016\/j.jcmg.2025.03.017_bib63","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jcmg.2020.10.019","article-title":"High-risk coronary plaque regression after intensive lifestyle intervention in nonobstructive coronary disease: a randomized study","volume":"14","author":"Henzel","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib64","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jcct.2016.08.003","article-title":"Prognostic implications of coronary CT angiography-derived quantitative markers for the prediction of major adverse cardiac events","volume":"10","author":"Tesche","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jamacardio.2023.5661","article-title":"Effects of pitavastatin on coronary artery disease and inflammatory biomarkers in HIV: mechanistic substudy of the REPRIEVE randomized clinical trial","volume":"9","author":"Lu","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib66","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ehjci\/jev325","article-title":"Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis","volume":"17","author":"Thomsen","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jamacardio.2021.5705","article-title":"Association of plaque location and vessel geometry determined by coronary computed tomographic angiography with future acute coronary syndrome-causing culprit lesions","volume":"7","author":"Han","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib68","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jcmg.2021.03.004","article-title":"Sex-specific computed tomography coronary plaque characterization and risk of myocardial infarction","volume":"14","author":"Williams","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jcct.2020.12.007","article-title":"Progression of whole-heart atherosclerosis by coronary CT and major adverse cardiovascular events","volume":"15","author":"van Rosendael","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jcmg.2025.03.017_bib70","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jcmg.2019.06.019","article-title":"Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events","volume":"13","author":"Andreini","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib71","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jcmg.2018.02.025","article-title":"Plaque morphology as predictor of late plaque events in patients with asymptomatic type 2 diabetes: a long-term observational study","volume":"12","author":"Halon","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib72","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/ehjci\/jex183","article-title":"Quantitative global plaque characteristics from coronary computed tomography angiography for the prediction of future cardiac mortality during long-term follow-up","volume":"18","author":"Hell","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib73","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jacc.2013.02.065","article-title":"Additive value of semiautomated quantification of coronary artery disease using cardiac computed tomographic angiography to predict future acute coronary syndrome","volume":"61","author":"Versteylen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib74","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230124","article-title":"Residual risk in non-ST-segment elevation acute coronary syndrome: quantitative plaque analysis at coronary CT angiography","volume":"308","author":"Lu","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.jcmg.2025.03.017_bib75","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231234","article-title":"Photon-counting CT: a step change leading to a revolution in coronary imaging","volume":"307","author":"Williams","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.jcmg.2025.03.017_bib76","first-page":"481","article-title":"Noninvasive fractional flow reserve derived from coronary computed tomography angiography for the diagnosis of lesion-specific ischemia","volume":"4","author":"Danad","year":"2015","journal-title":"Interv Cardiol Clin"},{"key":"10.1016\/j.jcmg.2025.03.017_bib77","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/ehjci\/jead063","article-title":"Benefit of icosapent ethyl on coronary physiology assessed by computed tomography angiography fractional flow reserve: EVAPORATE-FFRCT","volume":"24","author":"Rabbat","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.017_bib78","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(24)00596-8","article-title":"Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study","volume":"403","author":"Chan","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jcmg.2025.03.017_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41569-018-0097-6","article-title":"The role of adipose tissue in cardiovascular health and disease","volume":"16","author":"Oikonomou","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.017_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1359500","article-title":"Computed tomographic angiography measures of coronary plaque in clinical trials: opportunities and considerations to accelerate drug translation","volume":"11","author":"Howden","year":"2024","journal-title":"Front Cardiovasc Med"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X25002724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X25002724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:13:58Z","timestamp":1755098038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X25002724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":80,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1936878X25002724"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2025.03.017","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accelerating Drug Translation","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2025.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}